Sawtooth Solutions, LLC Ligand Pharmaceuticals Inc Transaction History

Sawtooth Solutions, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Sep 01, 2021	SELL	$113.03 - $155.64 $219,052 - $301,630	-1,938 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$99.52 - $215.83 $192,869 - $418,278	1,938 New	1,938 $295,000
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $115,909 - $245,733	-903 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$211.18 - $274.49 $190,695 - $247,864	903 New	903 $248,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Sawtooth Solutions, LLC with notifications on news.